Request a Quote

Cyprotex Highlights - September 2020


Throughout the October and November, we are hosting our second webinar series of 2020, this time focusing on the area of toxicology.

Each Wednesday, starting on the 21st October, a different speaker will be presenting on their latest research in this field. We have a great line up of speakers from ApconiX, Takeda, the University of Liverpool, & Cyprotex.

Learn more & reserve your seat

3D Brains

Throughout September, we presented a fantastic series of webinars showcasing the subject of drug transporters. Our colleagues from Novartis and Genentech joined us to present on this exciting topic.

If you missed the live webinars, don’t worry! You can re-watch the presentations here:

Watch on demand

Drug transporters

Cyprotex expert, Hollie Adey, presented at the Sciex User Meeting on the 8th September, discussing the role of the TripleTOF® in high-throughput ADME screening.

Her presentation, entitled: 'Are TripleTOF® systems the future for HT-ADME/toxicity screening?' is now available to download from our website.

Download the presentation

mitochondrial toxicity

On the 16th and 17th September, the Boston Society held their Tenth Annual HT-ADME Conference. Cyprotex was delighted to be able to contribute towards this virtual event and our in-house expert, Dr Sravani Adusumakki, presented a talk entitled: ‘Extreme High-throughput and Efficient Automated Workflow to Determine Blood to Plasma Ratio’.

If you missed the event or would like to watch the webinar again, click on the link below:

Watch the Webinar

mitochondrial toxicity

Read the latest news from parent company, Evotec:

  • Evotec and Secarna Pharmaceuticals form strategic partnership in the field of antisense oligonucleotide based therapeutics
  • Evotec receives funding for Resolute's antibiotic project from CARB-X
  • Evotec SE reports results and corporate updates for first half-year 2020
  • Evotec and Novo Nordisk form strategic partnership to develop novel therapies for kidney diseases
  • Evotec and CENTOGENE expand their existing drug discovery partnership collaboration into Gaucher disease
  • Evotec announces partnership agreement with University of Oxford to access biospecimens from QUOD biobank
  • Evotec takes on additional space at Milton Park, Abingdon, UK
  • Evotec and BIOASTER join forces to fight against infectious disease

Read the press releases

Read the press releases
Contact us

News categories


Contact us to discuss your ADME Tox issues or request a quote

Europe: +44 (0)1625 505100
North America (East Coast): +1-888-297-7683

or fill out the form below:


Download file